pazopanib

Generic: pazopanib

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pazopanib
Generic Name pazopanib
Labeler avkare
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

pazopanib hydrochloride 200 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-939
Product ID 42291-939_48c0ee87-f725-1a71-e063-6394a90a72d1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217517
Listing Expiration 2027-12-31
Marketing Start 2024-04-23

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291939
Hyphenated Format 42291-939

Supplemental Identifiers

RxCUI
867502
UNII
33Y9ANM545

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pazopanib (source: ndc)
Generic Name pazopanib (source: ndc)
Application Number ANDA217517 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 120 TABLET, FILM COATED in 1 BOTTLE (42291-939-12)
source: ndc

Packages (1)

42291-939-12 120 TABLET, FILM COATED in 1 BOTTLE (42291-939-12)

Ingredients (1)

pazopanib hydrochloride (200 mg/1)

Linked Drug Pages (1)

Pazopanib ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c0ee87-f725-1a71-e063-6394a90a72d1", "openfda": {"unii": ["33Y9ANM545"], "rxcui": ["867502"], "spl_set_id": ["16c5df52-0031-034d-e063-6294a90a1717"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (42291-939-12)", "package_ndc": "42291-939-12", "marketing_start_date": "20240423"}], "brand_name": "Pazopanib", "product_id": "42291-939_48c0ee87-f725-1a71-e063-6394a90a72d1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "42291-939", "generic_name": "Pazopanib", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pazopanib", "active_ingredients": [{"name": "PAZOPANIB HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "ANDA217517", "marketing_category": "ANDA", "marketing_start_date": "20240423", "listing_expiration_date": "20271231"}